MEREDITH WALL: Open Payments
NPI 1497475008 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 12 payments from 7 companies in 2025. Trend: 2023 $641 · 2024 $872 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: LEQVIO, JARDIANCE, ELIQUIS, VERQUVO, FARXIGA, FUROSCIX, NEXLETOL, CAMZYOS.
Industry payments across VA — which companies pay providers there.
